Cancer screening.

J Am Dent Assoc

Published: October 2008

Download full-text PDF

Source
http://dx.doi.org/10.14219/jada.archive.2008.0033DOI Listing

Publication Analysis

Top Keywords

cancer screening
4
cancer
1

Similar Publications

Contrast-enhanced mammography (CEM) is growing in clinical use due to its increased sensitivity and specificity compared to full-field digital mammography (FFDM) and/or digital breast tomosynthesis (DBT), particularly in patients with dense breasts. To perform an intraindividual comparison of MGD between FFDM, DBT, a combination protocol using both FFDM and DBT (combined FFDM-DBT), and CEM, in patients undergoing breast cancer screening. This retrospective study included 389 women (median age, 57.

View Article and Find Full Text PDF

This scoping review maps primary prevention and early detection strategies for oral and oropharyngeal cancer across national cancer plans and noncommunicable disease plans from all World Health Organization Member States. Following PRISMA-ScR guidelines, bibliographic search was performed on key organization websites until March 2023. Of the 194 countries assessed three had subnational plans, resulting in 264 self-governing political entities and similar with revised plans.

View Article and Find Full Text PDF

Hormone therapy and cancer risks in transgender people: a systematic review.

Epidemiol Serv Saude

January 2025

Ministério da Saúde, Secretaria de Atenção Especializada à Saúde, Brasília, DF, Brazil.

Objective: To identify the available evidence on the risk of developing cancer in transgender people undergoing hormone therapy.

Methods: This was a rapid systematic review conducted in the PubMed, Embase, Virtual Health Library, Cochrane Library and Epistemonikos databases. Screening and data extraction were performed by independent reviewers using the Rayyan platform.

View Article and Find Full Text PDF

Objective: To evaluate the impact of ART duration and CD4 count on risk for high grade cervical dysplasia in women with HIV (WWH) compared to women without HIV in the treat-all era with integrase strand inhibitors (INSTIs).

Design: Prospective longitudinal cohort study in Botswana.

Methods: From February 2021 to August 2022, baseline HPV self-sampling was offered to women with and without HIV.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!